Compare ETFs: IBB vs. LON:XDWH
IBB
LON:XDWH
Comparison
Average Return
In the past year, IBB returned a total of 22.61%, which is significantly higher than LON:XDWH's 2.52% return. Over the past 10 years, IBB has had annualized average returns of 6.80%, compared to 8.26% for LON:XDWH. These numbers are adjusted for stock splits and include dividends.
Top 25 Holdings
| IBB - iShares Biotechnology ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | GILD | Gilead Sciences, Inc. | 7.86% |
| 2 | AMGN | Amgen Inc. | 7.83% |
| 3 | VRTX | Vertex Pharmaceuticals Incorporated | 7.60% |
| 4 | REGN | Regeneron Pharmaceuticals, Inc. | 7.25% |
| 5 | ALNY | Alnylam Pharmaceuticals, Inc. | 4.03% |
| 6 | ARGX | argenx SE | 3.06% |
| 7 | INSM | Insmed Incorporated | 2.99% |
| 8 | BIIB | Biogen Inc. | 2.60% |
| 9 | NTRA | Natera, Inc. | 2.32% |
| 10 | UTHR | United Therapeutics Corporation | 2.14% |
| 11 | ONC | BeOne Medicines AG | 1.94% |
| 12 | MRNA | Moderna, Inc. | 1.73% |
| 13 | INCY | Incyte Corporation | 1.72% |
| 14 | ILMN | Illumina, Inc. | 1.69% |
| 15 | RVMD | Revolution Medicines, Inc. | 1.54% |
| 16 | ROIV | Roivant Sciences Ltd. | 1.25% |
| 17 | NBIX | Neurocrine Biosciences, Inc. | 1.21% |
| 18 | GMAB | Genmab A/S | 1.19% |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 1.13% |
| 20 | BBIO | BridgeBio Pharma, Inc. | 1.12% |
| 21 | MDGL | Madrigal Pharmaceuticals, Inc. | 1.03% |
| 22 | EXEL | Exelixis, Inc. | 1.01% |
| 23 | MEDP | Medpace Holdings, Inc. | 0.99% |
| 24 | BMRN | BioMarin Pharmaceutical Inc. | 0.99% |
| 25 | ASND | Ascendis Pharma A/S | 0.96% |
| View IBB holdings | |||
| LON:XDWH - Xtrackers MSCI World Health Care UCITS ETF | |||
|---|---|---|---|
| No. | Symbol | Name | Weight |
| 1 | LLY | Eli Lilly and Company | 10.03% |
| 2 | JNJ | Johnson & Johnson | 7.09% |
| 3 | ABBV | AbbVie Inc. | 4.86% |
| 4 | ROC1.L | Roche Holding AG | 3.97% |
| 5 | LON: AZN | AstraZeneca PLC | 3.84% |
| 6 | SWX: NOVN | Novartis AG | 3.82% |
| 7 | MRK | Merck & Co., Inc. | 3.66% |
| 8 | UNH | UnitedHealth Group Incorporated | 3.15% |
| 9 | AMGN | Amgen Inc. | 2.48% |
| 10 | ABT | Abbott Laboratories | 2.40% |
| 11 | TMO | Thermo Fisher Scientific Inc. | 2.33% |
| 12 | GILD | Gilead Sciences, Inc. | 2.19% |
| 13 | ISRG | Intuitive Surgical, Inc. | 2.14% |
| 14 | PFE | Pfizer Inc. | 1.86% |
| 15 | DHR | Danaher Corporation | 1.61% |
| 16 | SYK | Stryker Corporation | 1.58% |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 1.51% |
| 18 | BMY | Bristol-Myers Squibb Company | 1.50% |
| 19 | MDT | Medtronic plc | 1.48% |
| 20 | MCK | McKesson Corporation | 1.46% |
| 21 | CPH: NOVO.B | Novo Nordisk A/S | 1.44% |
| 22 | LON: GSK | GSK plc | 1.43% |
| 23 | BSX | Boston Scientific Corporation | 1.35% |
| 24 | EPA: SAN | Sanofi | 1.27% |
| 25 | CVS | CVS Health Corporation | 1.20% |
| View LON:XDWH holdings | |||